4D-310

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
19	ライソゾーム病	2

19. ライソゾーム病

臨床試験数 : 899 / 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05629559 (ClinicalTrials.gov)	October 16, 2022	4/11/2022	4D-310 in Adults With Fabry Disease and Cardiac Involvement	An Open-Label, Phase 1/2a Trial of Gene Therapy 4D-310in Adults With Fabry Disease and Cardiac Invol ...	Fabry Disease	Biological: 4D-310	4D Molecular Therapeutics	NULL	Active, not recruiting	18 Years	N/A	All	18	Phase 1/Phase 2	Australia;Taiwan
2	NCT04519749 (ClinicalTrials.gov)	September 1, 2020	14/8/2020	An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease	An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease	Fabry Disease	Biological: 4D-310	4D Molecular Therapeutics	NULL	Active, not recruiting	18 Years	N/A	All	18	Phase 1/Phase 2	United States

First Previous1Next Last